Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 38.51 is 52% above its 5-year average of 25.32, around the middle of its 5-year range (15.56–59.01).
As of the fiscal period ended Tuesday, June 30, 2026. 49.28% above its 12-month average of 25.80.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 38.51.
QUICK RATIO (ACID-TEST)
38.51
QUICK RATIO (ACID-TEST) AVG TTM
25.80
QUICK RATIO (ACID-TEST) AVG 3Y
27.11
QUICK RATIO (ACID-TEST) AVG 5Y
25.32
QUICK RATIO (ACID-TEST) AVG 10Y
18.58
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+49.28%
CURRENT VS 3Y AVG
+42.08%
CURRENT VS 5Y AVG
+52.13%
CURRENT VS 10Y AVG
+107.29%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 752 covered companies
CURRENT VS SECTOR MEDIAN
+1105.40%
vs the sector median at left
Oruka Therapeutics, Inc.
Market Cap
$4.84B
Quick Ratio (Acid-Test)
38.51
TTM Avg
25.80
3Y Avg
27.11
5Y Avg
25.32
Market Cap
$4.82B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.86B
Quick Ratio (Acid-Test)
2.74
TTM Avg
2.74
3Y Avg
3.13
5Y Avg
4.87
Market Cap
$4.70B
Quick Ratio (Acid-Test)
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.69B
Quick Ratio (Acid-Test)
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.40
Market Cap
$4.65B
Quick Ratio (Acid-Test)
0.98
TTM Avg
1.08
3Y Avg
1.21
5Y Avg
1.19
Market Cap
$5.09B
Quick Ratio (Acid-Test)
2.79
TTM Avg
2.90
3Y Avg
2.74
5Y Avg
2.21
Market Cap
$4.56B
Quick Ratio (Acid-Test)
11.31
TTM Avg
9.52
3Y Avg
6.89
5Y Avg
6.89
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | $4.84B | 38.51 | 25.80 | 27.11 | 25.32 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.82B | 26.10 | 14.27 | 14.23 | 14.47 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.86B | 2.74 | 2.74 | 3.13 | 4.87 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.70B | 6.95 | 6.77 | 6.23 | 10.87 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 1.38 | 1.51 | 1.37 | 1.40 |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 0.98 | 1.08 | 1.21 | 1.19 |
| Erasca, Inc. (ERAS)vs › | $5.05B | 8.29 | 9.94 | 10.32 | 11.01 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.09B | 2.79 | 2.90 | 2.74 | 2.21 |
| BillionToOne, Inc. (BLLN)vs › | $4.56B | 11.31 | 9.52 | 6.89 | 6.89 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.13B | 7.02 | 8.28 | 8.59 | 7.77 |
Quick Ratio
38.51
Excludes inventory
Current Ratio
38.51
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 38.51 |
| 2026-03-31 | 23.76 |
| 2025-12-31 | 22.37 |
| 2025-09-30 | 16.94 |
| 2025-06-30 | 27.42 |
| 2025-03-31 | 30.03 |
| 2024-12-31 | 28.89 |
| 2024-09-30 | 22.89 |
| 2024-06-30 | 26.61 |
| 2024-03-31 | 23.19 |
| 2023-12-31 | 59.01 |
| 2023-09-30 | 39.21 |
| 2023-06-30 | 25.44 |
| 2023-03-31 | 32.94 |
| 2022-12-31 | 37.72 |
| 2022-09-30 | 23.00 |
| 2022-06-30 | 16.97 |
| 2022-03-31 | 18.59 |
| 2021-12-31 | 15.56 |
| 2021-09-30 | 18.75 |
| 2021-06-30 | 17.54 |
| 2021-03-31 | 23.86 |
| 2020-12-31 | 14.28 |
| 2020-09-30 | 34.01 |
| 2020-06-30 | 8.71 |
| 2020-03-31 | 6.39 |
| 2019-12-31 | 9.16 |
| 2019-09-30 | 8.61 |
| 2019-06-30 | 8.61 |
| 2019-03-31 | 6.61 |
| 2018-12-31 | 8.55 |
| 2018-09-30 | 8.58 |
| 2018-06-30 | 9.44 |
| 2018-03-31 | 7.40 |
| 2017-12-31 | 5.94 |
| 2017-09-30 | 6.44 |
| 2017-06-30 | 6.61 |
| 2017-03-31 | 7.88 |
